Phibro Animal Health (NASDAQ:PAHC) Stock Jumps 3.2% – Here’s Why

Phibro Animal Health Corporation (NASDAQ:PAHC)’s share price traded up 3.2% during mid-day trading on Wednesday. The stock traded as high as $38.10 and last traded at $37.9760. Approximately 30,350 shares were traded during trading, a decline of 89% from the average session volume of 288,020 shares. The stock had previously closed at $36.81.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Phibro Animal Health in a research report on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, Phibro Animal Health has an average rating of “Moderate Buy” and a consensus target price of $47.67.

Phibro Animal Health Stock Performance

The business has a 50-day moving average of $36.09 and a two-hundred day moving average of $38.49. The company has a market cap of $1.54 billion, a P/E ratio of 11.82, a P/E/G ratio of 1.10 and a beta of 0.42. The company has a debt-to-equity ratio of 1.84, a current ratio of 2.96 and a quick ratio of 1.27.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.14. The business had revenue of $396.75 million during the quarter, compared to the consensus estimate of $381.18 million. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. On average, sell-side analysts predict that Phibro Animal Health Corporation will post 3.50 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Wednesday, September 2nd were given a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, September 2nd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.3%. Phibro Animal Health’s payout ratio is presently 19.67%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of PAHC. Renaissance Technologies LLC boosted its stake in Phibro Animal Health by 5.8% in the first quarter. Renaissance Technologies LLC now owns 576,735 shares of the company’s stock valued at $31,899,000 after acquiring an additional 31,435 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Phibro Animal Health by 3.2% during the first quarter. Dimensional Fund Advisors LP now owns 507,852 shares of the company’s stock worth $28,086,000 after purchasing an additional 15,517 shares in the last quarter. Ranger Investment Management L.P. acquired a new position in shares of Phibro Animal Health during the second quarter worth $9,182,000. Allspring Global Investments Holdings LLC lifted its holdings in shares of Phibro Animal Health by 145.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 286,172 shares of the company’s stock valued at $15,671,000 after purchasing an additional 169,628 shares during the last quarter. Finally, Capricorn Fund Managers Ltd lifted its holdings in shares of Phibro Animal Health by 45.1% during the 1st quarter. Capricorn Fund Managers Ltd now owns 267,045 shares of the company’s stock valued at $14,770,000 after purchasing an additional 82,944 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) develops, manufactures and distributes products that support animal health, nutrition and performance. The company serves livestock producers, veterinarians, feed manufacturers and other customers across the food-animal and companion-animal markets.

Its portfolio includes animal health products such as vaccines, medicated feed additives and other solutions used to help prevent and manage disease. Phibro also provides mineral nutrition products, feed additives and performance solutions designed to support animal growth, feed efficiency, health and productivity.

Phibro Animal Health traces its roots to 1916 and operates internationally, serving customers in the United States and markets around the world.